相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment
S. M. Proudman et al.
INTERNAL MEDICINE JOURNAL (2007)
Systemic sclerosis: a prototypic multisystem fibrotic disorder
John Varga et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis
Lazaros I. Sakkas et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe?
Andriana I. Papaioannou et al.
RESPIRATORY RESEARCH (2006)
Systemic inflammation in patients with COPD and pulmonary hypertension
Pavol Joppa et al.
CHEST (2006)
Systemic and locatized scleroderma
Lorinda Chung et al.
CLINICS IN DERMATOLOGY (2006)
Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease
AR Kranenburg et al.
THORAX (2005)
Screening, early detection, and diagnosis of pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines
M McGoon et al.
CHEST (2004)
Diagnosis and differential assessment of pulmonary arterial hypertension
RJ Barst et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension
E Mata-Greenwood et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients
K Asai et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Evaluation and management of pulmonary hypertension in systemic sclerosis
IR Preston et al.
CURRENT OPINION IN RHEUMATOLOGY (2003)
Pulmonary hypertension in TNF-α-overexpressing mice is associated with decreased VEGF gene expression
M Fujita et al.
JOURNAL OF APPLIED PHYSIOLOGY (2002)
Janus face of vascular endothelial growth factor: The obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension
NF Voelkel et al.
CRITICAL CARE MEDICINE (2002)
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers
O Distler et al.
ARTHRITIS RESEARCH (2002)
Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension
AIM Campbell et al.
CIRCULATION (2001)
Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis
RM Tuder et al.
JOURNAL OF PATHOLOGY (2001)
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension
L Taraseviciene-Stewart et al.
FASEB JOURNAL (2001)
Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension -: Effect of prostacyclin therapy
S Eddahibi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension
S Hirose et al.
PATHOLOGY INTERNATIONAL (2000)
Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease
KC Meyer et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2000)
分享论文
